RE:RE:Parasitic merger? No thanksDoes a 'no' vote derail the access to capital the merger provides to accelerate CZO's plans for significant growth given the many opportunities in Friday's news release. Would it cause delays in CZO's plan? Would it also cause a new round of costs as CZO is forced to re-evaluate its strategic alternatives and potentially find a new merger partner over the next year and go through this process again. This would take resources off their plan for growth immediatly ahead. Will the extra costs and delays require a potential financing with warrants. How much cash does CZO have left after ramping up the pill trial, simultaneous PGX scale-up at 5X and 10X(with Natex), and given the significant costs of the merger, etc. How many more millions if CZO is to go through this merger process again.
“We are thrilled with this exciting transaction to merge with Aeterna and combine two complementary companies and teams, in support of our plan to drive significant growth,” said Ronnie Miller, Chairman of Ceapro. “After careful consideration, we believe this transaction is the best way forward for Ceapro and our valued shareholders.”